Features of the quality of life in patients with vitiligo

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access


BACKGROUND: Vitiligo is an acquired skin disease whose etiology is still unknown. It is observed in 0.5–1% of the world population. Medical and social significance is due to the impact on the psychological state of the patient and the quality of his life.

AIMS: Analysis of the quality of life index in patients suffering from vitiligo.

MATERIALS AND METHODS: The results of questionnaires filled out by 150 patients (95 women and 55 men) suffering from vitiligo were studied in the work. The average age of the subjects was 34.56±1.73 years. A survey was conducted among the subjects: patients were asked questions from a questionnaire specially developed by us. The work also used the Dermatological Life Quality Index (DIQI). The questionnaire was filled in by all patients independently at the initial examination. The results were processed using Microsoft Excel from the Microsoft Office software package and the Statistica software package for statistical analysis.

RESULTS: The data obtained indicate that in all responses to the questions, the largest number of statements were classified as “strongly/very strongly”. This fact indicates a significant impact of this pathology on the quality of life of the subjects. The DLQI results also confirmed that the presence of vitiligo limits a person’s quality of life to the maximum (in 41.3% of cases) and has a large negative impact (in 53.3% of cases).

CONCLUSION: Performing further research on the study of quality of life in patients suffering from vitiligo is one of the promising areas for developing a personalized approach to managing this group of patients.

Full Text

Restricted Access

About the authors

Makhabbat Lecaillon

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Author for correspondence.
Email: askmaha@mail.ru
ORCID iD: 0000-0003-4767-3002
Scopus Author ID: 57219593105
ResearcherId: AHB-8722-2022


Russian Federation, Moscow

Konstantin M. Lomonosov

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Email: lamclinic@yandex.ru
ORCID iD: 0000-0002-4580-6193
SPIN-code: 4784-9730

MD, Dr. Sci. (Med.), Professor

Russian Federation, Moscow


  1. Zhang Y, Cai Y, Shi M, et al. The prevalence of vitiligo: a meta-analysis. PLoS One. 2016;11(9):e0163806. doi: 10.1371/journal.pone.0163806
  2. Rodrigues M, Ezzedine K, Hamzavi I, et al.; Vitiligo Working Group. New discoveries in the pathogenesis and classification of vitiligo. J Am Acad Dermatol. 2017;77(1):1–13. doi: 10.1016/j.jaad.2016.10.048
  3. Frisoli ML, Essien K, Harris JE. Vitiligo: mechanisms of pathogenesis and treatment. Annu Rev Immunol. 2020;38. 621–648. doi: 10.1146/annurev-immunol-100919-023531
  4. Lei TC, Xu AE, Gao TW, et al. The vitiligo expert group of the dermatovenereology professional committee, chinese society of integrated chinese and western medicine consensus on the diagnosis and treatment of vitiligo in China (2021 Revision). Int J Dermatol Venereol. 2021;4(1):10–15. doi: 10.1097/JD9.0000000000000151
  5. Chen D, Tuan H, Zhou EY, et al. Quality of life of adult vitiligo patients using camouflage: a survey in a Chinese vitiligo community. PLoS ONE. 2019;14(1):e0210581. doi: 10.1371/journal.pone.0210581
  6. Lacerda KA, Silva LA, Mendonca GS, et al. Association between quality of life and perceived stress in patients with vitiligo: case control study. Bioscience J. 2020;36(3):1032–1042. doi: 10.14393/BJ-v36n3a2020-45105
  7. Grimes PE, Miller MM. Vitiligo: patient stories, self-esteem, and the psychological burden of disease. Int J Womens Dermatol. 2018;4(1):32–37. doi: 10.1016/j.ijwd.2017.11.005
  8. Osinubi O, Grainge MJ, Hong L, et al. The prevalence of psychological comorbidity in people with vitiligo: a systematic review and meta-analysis. Br J Dermatol. 2018;178(4):863–878. doi: 10.1111/bjd.16049
  9. Annella G, Greco A, Didona D, et al. Vitiligo: pathogenesis, clinical variants and treatment approaches. Autoimmun Rev. 2016;15(4):335–343. doi: 10.1016/j.autrev.2015.12.006
  10. Kundu RV, Mhlaba JM, Rangel SM, Le Poole IC. The convergence theory for vitiligo. A reappraisal. Exp Dermatol. 2019;28(6):647–655. doi: 10.1111/exd.13677
  11. Bae JM, Jung HM, Hong BY. Phototherapy for vitiligo: a systematic review and meta-analysis. JAMA Dermatol. 2017;153(7):666–674. doi: 10.1001/jamadermatol.2017.0002
  12. Vovdenko KA, Lekayon M, Lomonosov KM. Methods of camouflage of vitiligo (literature review.) Russ J Skin Venereal Diseases. 2021;24(2):161–166. (In Russ). doi: 10.17816/dv63945

Supplementary files

Supplementary Files
1. Fig. 1. Comparative characteristics of the results obtained when answering the questions of the questionnaire filled out by respondents (in percentage ratio).Note: The reliability of the difference of the trait between the groups: * p <0.05; ** p <0.01.

Download (130KB)
2. Fig. 2. Comparative characteristics of the structure of respondents by the level of influence of vitiligo on the quality of life (95% confidence interval for fractions).

Download (129KB)

Copyright (c) 2022 Eco-Vector

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: 015912 от 28.03.1997 г
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ЭЛ № ФС 77 - 80653 от 15.03.2021 г

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies